Profil
Diala Ezzeddine is a trustee at Buckingham Browne & Nichols School and the president of Xios Therapeutics, Inc. She previously worked as the chief business officer at X-Chem, Inc.
Postes actifs de Diala Ezzeddine
| Sociétés | Poste | Début |
|---|---|---|
Xios Therapeutics, Inc.
Xios Therapeutics, Inc. BiotechnologyHealth Technology Develops novel small molecule therapeutics capable of preventing tumors | President | - |
Buckingham Browne & Nichols School
Buckingham Browne & Nichols School Other Consumer ServicesConsumer Services Operates as school | Directeur/Membre du Conseil | - |
Anciens postes connus de Diala Ezzeddine
| Sociétés | Poste | Fin |
|---|---|---|
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Buckingham Browne & Nichols School
Buckingham Browne & Nichols School Other Consumer ServicesConsumer Services Operates as school | Consumer Services |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services Provides DNA-encoded library-based drug discovery technology services | Technology Services |
Xios Therapeutics, Inc.
Xios Therapeutics, Inc. BiotechnologyHealth Technology Develops novel small molecule therapeutics capable of preventing tumors | Health Technology |
















